These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9834222)

  • 21. A novel (288delC) mutation in exon 2 of GPIIb associated with type I Glanzmann's thrombasthenia.
    Tao J; Arias-Salgado EG; González-Manchón C; Díaz-Cremades J; Ayuso MS; Parrilla R
    Br J Haematol; 2000 Oct; 111(1):96-103. PubMed ID: 11091187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A mutation in the β3 cytoplasmic tail causes variant Glanzmann thrombasthenia by abrogating transition of αIIb β3 to an active state.
    Hauschner H; Mor-Cohen R; Seligsohn U; Rosenberg N
    J Thromb Haemost; 2012 Feb; 10(2):289-97. PubMed ID: 22136613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A beta3 Asp217-->Val substitution in a patient with variant Glanzmann Thrombasthenia severely affects integrin alphaIIBbeta3 functions.
    D'Andrea G; Bafunno V; Del Vecchio L; Amoriello A; Morabito P; Vecchione G; Grandone E; Margaglione M
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):657-62. PubMed ID: 18832906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunisation against αIIbβ3 and αvβ3 in a type 1 variant of Glanzmann's thrombasthenia caused by a missense mutation Gly540Asp on β3.
    Wihadmadyatami H; Röder L; Berghöfer H; Bein G; Heidinger K; Sachs UJ; Santoso S
    Thromb Haemost; 2016 Aug; 116(2):262-71. PubMed ID: 27098940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a region in glycoprotein IIIa involved in subunit association with glycoprotein IIb: further lessons from Iraqi-Jewish Glanzmann thrombasthenia.
    Yatuv R; Rosenberg N; Zivelin A; Peretz H; Dardik R; Trakhtenbrot L; Seligsohn U
    Blood; 2001 Aug; 98(4):1063-9. PubMed ID: 11493452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A deletion in the alpha subunit locks platelet integrin alpha IIb beta 3 into a high affinity state.
    Peter K; Bode C
    Blood Coagul Fibrinolysis; 1996 Mar; 7(2):233-6. PubMed ID: 8735827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triple heterozygosity in the integrin alphaIIb subunit in a patient with Glanzmann's thrombasthenia.
    Nurden AT; Breillat C; Jacquelin B; Combrié R; Freedman J; Blanchette VS; Schmugge M; Rand ML
    J Thromb Haemost; 2004 May; 2(5):813-9. PubMed ID: 15099289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A point mutation in the integrin beta 3 cytoplasmic domain (S752-->P) impairs bidirectional signaling through alpha IIb beta 3 (platelet glycoprotein IIb-IIIa).
    Chen YP; O'Toole TE; Ylänne J; Rosa JP; Ginsberg MH
    Blood; 1994 Sep; 84(6):1857-65. PubMed ID: 8080992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An exon 28 mutation resulting in alternative splicing of the glycoprotein IIb transcript and Glanzmann's thrombasthenia.
    Iwamoto S; Nishiumi E; Kajii E; Ikemoto S
    Blood; 1994 Feb; 83(4):1017-23. PubMed ID: 8111043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Description of 10 new mutations in platelet glycoprotein IIb (alphaIIb) and glycoprotein IIIa (beta3) genes.
    Vinciguerra C; Bordet JC; Beaune G; Grenier C; Dechavanne M; Négrier C
    Platelets; 2001 Dec; 12(8):486-95. PubMed ID: 11798398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel point mutations in the alphaIIb subunit (Phe289-->Ser, Glu324-->Lys and Gln747-->Pro) causing thrombasthenic phenotypes in four Japanese patients.
    Ambo H; Kamata T; Handa M; Kawai Y; Oda A; Murata M; Takada Y; Ikeda Y
    Br J Haematol; 1998 Aug; 102(3):829-40. PubMed ID: 9722314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glanzmann's thrombasthenia due to a point mutation within intron 10 results in aberrant splicing of the beta3 gene.
    Tanaka S; Hayashi T; Terada C; Hori Y; Han KS; Ahn HS; Bourre F; Tani Y
    J Thromb Haemost; 2003 Nov; 1(11):2427-33. PubMed ID: 14629479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel 196Leu to Pro substitution in the beta3 subunit of the alphaIIbbeta3 integrin in a patient with a variant form of Glanzmann thrombasthenia.
    Nurden AT; Ruan J; Pasquet JM; Gauthier B; Combrié R; Kunicki T; Nurden P
    Platelets; 2002 Mar; 13(2):101-11. PubMed ID: 11897046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection by PCR and HphI restriction analysis of a splice site mutation at the 5' end of intron 15 of the platelet GPIIb (alpha IIb integrin) gene responsible for Glanzmann's thrombasthenia type I in Gypsies originating from the Strasbourg area.
    de la Salle C; Schwartz A; Baas MJ; Lanza F; Cazenave JP
    Thromb Haemost; 1995 Sep; 74(3):990-1. PubMed ID: 8571335
    [No Abstract]   [Full Text] [Related]  

  • 35. [Molecular mechanisms of Glanzmann thrombasthenia caused by alphaII b P126H mutation: an in vitro experiment].
    Shen WZ; Li SM; Jin PP; Ding QL; Wang XF; Jiang YZ; Wang HL
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1832-6. PubMed ID: 19040019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A spontaneous mutation of integrin alpha IIb beta 3 (platelet glycoprotein IIb-IIIa) helps define a ligand binding site.
    Bajt ML; Ginsberg MH; Frelinger AL; Berndt MC; Loftus JC
    J Biol Chem; 1992 Feb; 267(6):3789-94. PubMed ID: 1371279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Val193Met mutation in GPIIIa results in a GPIIb/IIIa receptor with a constitutively high affinity for a small ligand.
    Fullard J; Murphy R; O'Neill S; Moran N; Ottridge B; Fitzgerald DJ
    Br J Haematol; 2001 Oct; 115(1):131-9. PubMed ID: 11722423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bilateral linkage between a new deletion polymorphism in intron 21 of the GP IIb gene and the HPA-3b (Bakb) determinant.
    Peyruchaud O; Nurden A; Bourre F
    Br J Haematol; 1995 Nov; 91(3):747-51. PubMed ID: 8555087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Classification of Iranian patients with Glanzmann's Thrombasthenia using a flow cytometric method.
    Farsinejad A; Abolghasemi H; Kazemi A; Aghaiipour M; Hadjati E; Faranoush M; Jazebi M; Ala F
    Platelets; 2011; 22(5):321-7. PubMed ID: 21526886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Probing conformational changes in the I-like domain and the cysteine-rich repeat of human beta 3 integrins following disulfide bond disruption by cysteine mutations: identification of cysteine 598 involved in alphaIIbbeta3 activation.
    Chen P; Melchior C; Brons NH; Schlegel N; Caen J; Kieffer N
    J Biol Chem; 2001 Oct; 276(42):38628-35. PubMed ID: 11507099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.